PROCEPT BioRobotics Corp (PRCT)
93.60
-0.85
(-0.90%)
USD |
NASDAQ |
Nov 22, 16:00
95.78
+2.18
(+2.33%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Financing (Quarterly): 1.715M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.715M |
| June 30, 2024 | 5.296M |
| March 31, 2024 | 2.586M |
| December 31, 2023 | 2.866M |
| September 30, 2023 | 162.12M |
| June 30, 2023 | 2.43M |
| March 31, 2023 | 0.38M |
| December 31, 2022 | -1.318M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.777M |
| June 30, 2022 | 2.862M |
| March 31, 2022 | 1.291M |
| December 31, 2021 | 0.644M |
| September 30, 2021 | 174.12M |
| June 30, 2021 | 86.12M |
| March 31, 2021 | 1.225M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.318M
Minimum
Dec 2022
174.12M
Maximum
Sep 2021
29.54M
Average
2.43M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Intuitive Surgical Inc | 98.20M |
| Teleflex Inc | -174.82M |
| RxSight Inc | 0.878M |
| Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.80M |
| Cash from Investing (Quarterly) | -0.246M |
| Free Cash Flow | -103.56M |
| Free Cash Flow Per Share (Quarterly) | -0.3662 |
| Free Cash Flow to Equity (Quarterly) | -19.08M |
| Free Cash Flow Yield | -2.16% |